AWA
OPTN

Arete Wealth Advisors’s OptiNose OPTN Stock Holding History

Arete Wealth Advisors’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-667
Closed -$10K – 794
2024
Q2 		$10K Buy
+667
New +$11.2K ﹤0.01% 721
2024
Q1 		– Sell
-667
Closed -$12.9K – 625
2023
Q4 		$12.9K Hold
667
– – ﹤0.01% 732
2023
Q3 		$12.3K Hold
667
– – ﹤0.01% 496
2023
Q2 		$12K Hold
667
– – ﹤0.01% 661
2023
Q1 		$19K Buy
+667
New +$17.8K ﹤0.01% 637
2022
Q4 		– Sell
-800
Closed -$44K – 686
2022
Q3 		$44K Buy
+800
New +$43.9K ﹤0.01% 560
2022
Q2 		– Sell
-800
Closed -$30K – 535
2022
Q1 		$30K Hold
800
– – ﹤0.01% 501
2021
Q4 		$19K Buy
+800
New +$26.8K ﹤0.01% 501

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Arete Wealth Advisors's OPTN Position: Q3 2024 in Review

Arete Wealth Advisors sold out of OptiNose (OPTN) in Q3 2024, closing a stake of 667 shares — an estimated $10K sold.

Arete Wealth Advisors first reported a position in OPTN in Q4 2021 and held it in 8 quarters. The position peaked at $44K in Q3 2022. 65 funds tracked by Wall St. Rank hold OPTN as of Q3 2024.

  • Arete Wealth Advisors reported no remaining OptiNose position as of Q3 2024 after selling out during the quarter.
  • Arete Wealth Advisors sold 667 OptiNose shares in Q3 2024, an estimated $10K.
  • Arete Wealth Advisors first reported a position in OptiNose in Q4 2021 and held it in 8 quarters.
  • Arete Wealth Advisors's OptiNose position peaked at $44K in Q3 2022.
  • 65 funds tracked by Wall St. Rank held OptiNose as of Q3 2024.

Based on Arete Wealth Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.